Krosyl Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 10 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.14 Cr
- Revenue Growth -7.94%
- Profit Growth -5.98%
- Ebitda 37.69%
- Net Worth 75.73%
- Total Assets 135.00%
About Krosyl Pharmaceuticals
Krosyl Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 January 2015 and has a history of Ten years. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.14 Cr.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2015PTC081717
-
Company No.
081717
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Krosyl Pharmaceuticals Private Limited offer?
Krosyl Pharmaceuticals Private Limited offers a wide range of products and services, including Allopathic Cough Syrup, Anti Cold Syrup, Guaiphenesin Cough Syrup.
Who are the key members and board of directors at Krosyl Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parth Joshi
|
Director | 05-Jan-2015 | Current |
|
Nilesh Prajapati
|
Director | 05-Jan-2015 | Current |
Financial Performance of Krosyl Pharmaceuticals.
Krosyl Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.94% decrease. The company also saw a slight decrease in profitability, with a 5.98% decrease in profit. The company's net worth Soared by an impressive increase of 75.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krosyl Pharmaceuticals?
In 2023, Krosyl Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹71.38 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 7.04 Cr
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2023 | Others | ₹0.95 M | Open |
| 13 Aug 2020 | Bank Of India | ₹0.18 M | Open |
| 30 May 2020 | Bank Of India | ₹0.25 M | Open |
| 24 Jan 2017 | Bank Of India | ₹7.00 Cr | Open |
How Many Employees Work at Krosyl Pharmaceuticals?
Unlock and access historical data on people associated with Krosyl Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krosyl Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krosyl Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
